Skip to main content

Table 1 Patient characteristics

From: Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

Characteristics

No. of patients (%)

Total number

42 (100%)

Male/Female

26/16 (61.9/38.1)

Age (years)

 

   median

73

   range

70–81

Performance Status

 

   ECOG 0

18 (42.8)

   ECOG 1

24 (57.2)

Tumor differentiation

 

   Well differentiated

10 (23.8)

   Moderately differentiated

13 (30.9)

   Poorly differentiated or undifferentiated

19 (45.3)

Locally advanced disease

10 (23.8)

Metastatic disease

32 (76.2)

Number of metastases

 

   1

16 (38.2)

   2

19 (45.2)

   3+

7 (16.6)

Sites of metastases

 

   Liver

20 (47.6)

   Peritoneum

9 (21.4)

   Nodes

22 (52.4)

   Local

15 (35.7)

   Other

6 (14.3)

Prior adjuvant chemotherapy

 

   None

35 (83.3)

   Yes

7 (16.7)

Patients with metastases at the diagnosis

18 (42.8)

Number of cycles

 

   Total

540

   Median

12

   Range

3–24